Topics:

(ACR2014) In this video interview, Genentech's Vice President for Immunology and Infectious Diseases gives the company's latest information about safe uses of the classic biologic.

In patients taking SGLT2 inhibitors who had treated hypertension, a new study compared the drop in blood pressure seen with a diuretic to declines seen with other classes of antihypertensive medications.

MRI proves itself as a valuable tool for pinpointing inflammatory and structural damage in select rheumatoid arthritis patients.

This weekly roundup of breaking cardiology news is brought to our readers by our partners at MedPage Today.

The use of a stroke emergency mobile unit speeds thrombolysis and thus improves short-term outcomes, with no risk to patients’ safety.

The mechanism underlying the ability of empagliflozin to reduce measures of visceral adiposity may be a redistribution of fat to less vulnerable body areas.

New data boosts confidence in drug therapies for osteoporosis, but more research in older adults is required.

The end of the year is a good time to a handle performance reviews. They are a key part of the process to encourage continued success and stellar performance.

More diagnostic imaging tests are ordered by advanced practice clinicians than by primary care physicians.

Pages

Subscribe to Psychiatric Times RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.